BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20452237)

  • 21. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.
    Marchevsky AM; Patel S; Wiley KJ; Stephenson MA; Gondo M; Brown RW; Yi ES; Benedict WF; Anton RC; Cagle PT
    Mod Pathol; 1998 Jul; 11(7):618-25. PubMed ID: 9688182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
    Hsu NY; Ho HC; Chow KC; Lin TY; Shih CS; Wang LS; Tsai CM
    Cancer Res; 2001 Mar; 61(6):2727-31. PubMed ID: 11289154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
    Bozcuk H; Gumus A; Ozbilim G; Sarper A; Kucukosmanoglu I; Ozbudak IH; Artac M; Ozdogan M; Samur M; Kaya A; Savas B
    Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor expression in pN2 non-small cell lung cancer: lack of prognostic value.
    Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Respirology; 2005 Jan; 10(1):31-5. PubMed ID: 15691235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
    Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
    J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker.
    Sayar A; Turna A; Solak O; Kiliçgün A; Urer N; Gürses A
    Ann Thorac Surg; 2004 Feb; 77(2):421-5. PubMed ID: 14759409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Establishment and evaluation of a prognostic prediction model for patients after complete resection of non-small cell lung cancer and multidisciplinary therapy].
    Wei WD; Fu JH; Lin P; Li XD; Yang H; Rong TH; Chen LK
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):672-5. PubMed ID: 19173908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
    Watanabe S; Asamura H; Suzuki K; Tsuchiya R
    Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer.
    Yilmaz A; Ernam D; Unsal E; Demirag F; Atikcan S; Taştepe I
    Arch Med Res; 2007 Oct; 38(7):764-8. PubMed ID: 17845896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of smoking status in operated non-small cell lung cancer.
    Sardari Nia P; Weyler J; Colpaert C; Vermeulen P; Van Marck E; Van Schil P
    Lung Cancer; 2005 Mar; 47(3):351-9. PubMed ID: 15713518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
    Iizasa T; Suzuki M; Yasufuku K; Iyoda A; Otsuji M; Yoshida S; Sekine Y; Shibuya K; Saitoh Y; Hiroshima K; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1896-902; discussion 1902-3. PubMed ID: 15172232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
    J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.